Skip to content

To check the effect of Plum Vitamin C serum for skin brightening.

A single blind clinical study to evaluate the effectiveness and Safety of Plum Vitamin C serum for skin brightening. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056537
Enrollment
36
Registered
2023-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Plum vitamin C serum: Route of administration: Topical, Frequency :1 gm twice in a day, Duration: 28 days Control Intervention1: Not applicable: Not applicable

Sponsors

Pureplay skin sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Gender: Non-pregnant, non-lactating female aged between 18 to 34 2. Subject willing to give written informed consent 3. Women of child bearing potential must have a negative urine pregnancy test 4. Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE. 5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breast feeding, or planning to become pregnant during the study 2. Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition. 3. Have open sore or open lesions in the treatment area 4. Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product. 5. Have participated in any interventional clinical trial in the previous 30 days. 6.Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents. 7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids. 8. Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

MeasureTime frame
1. Change in percentage of consumers achieved a visible even tone skin/texture in 30 days. 2. Change in percentage of volunteers achieved a visibly brighter skin in 30 days. 3. Change in percentage of volunteers achieved a glowing skin in 30 days. 4. Change in percentage of volunteers experienced visible reduction of dark spot/ hyperpigmentation in 30 days 5. Change in percentage of volunteers experienced how much percentage of improvement in skin tone/texture.Timepoint: Day14, Day 28

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026